Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAPZA1 pseudogene 2 (CAPZA1P2) is a pseudogene, meaning it is a non-functional genomic sequence that bears similarity to the CAPZA1 gene which encodes the F-actin-capping protein subunit alpha-1. Unlike the functional CAPZA1 gene, CAPZA1P2 does not code for an active protein and therefore does not have any known biological function, disease associations, or drug interactions. Pseudogenes arise from gene duplication or retrotransposition and typically lack therapeutic relevance[5]. The functional CAPZA1 gene (capping actin protein of muscle Z-line subunit alpha 1) is an actin-binding protein involved in the regulation of actin filament growth, and has some disease associations (such as Focal Segmental Glomerulosclerosis 1 and Nemaline Myopathy)[1][3]. However, CAPZA1P2 itself is solely a pseudogene reference and should not be confused with the true therapeutic protein target. If the therapeutic target intended was CAPZA1, refer to "F-actin-capping protein subunit alpha-1" instead[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CAPZA1 pseudogene 2 (CAPZA1P2).